Royalties and Milestone Payments. EYEFITE shall be obligated to make to PHS, for as long as the PHS Agreement is in effect and obligates CANFITE to make any payments to PHS, the following Royalty, Milestone and Sublicensing payments to PHS under the PHS Agreement, as follows:
Royalties and Milestone Payments. 5.1 (a) The Licensee shall also pay to The Regents an EARNED ROYALTY of [***] of the Net Sales of Licensed Products, provided that the earned royalty shall be [***] of Net Sales of a Licensed Product if Net Sales of the Licensed Product are less than [***] per year in any given calendar year of sales. ***Confidential Treatment Requested 10
Royalties and Milestone Payments. 5.1 As part of the consideration for the rights granted by the Licensor to the Licensee under this Agreement, the Licensee will pay to the Licensor, on a quarterly basis, an annual royalty of *****% of annual Net Revenue and *****% of annual Sublicensing Revenue (collectively, the “Royalties”).
Royalties and Milestone Payments. 5.1 In consideration of the license granted hereunder, the Licensee shall pay to the University a royalty comprised of [***] of the Revenue.
Royalties and Milestone Payments. The royalties and Milestone Payments that are payable under the License Agreement shall be as set forth in the License Agreement. For clarity, the Company shall not be required to pay any royalties or Milestone Payments with respect to the Grandfathered AIP Compounds or Grandfathered Intent to Access Compounds.
Royalties and Milestone Payments. SECTION 6.1 Subject to the terms and conditions of this AGREEMENT, and as consideration for the licenses granted under this AGREEMENT, CUBIST shall pay to the UNIVERSITY an earned royalty of [ * ] of NET SALES of the [ * ] launched by CUBIST [ * ]. CUBIST shall pay to * Confidential Treatment Requested. Omitted portions filed with the Commission. the UNIVERSITY an earned royalty of [ * ] of NET SALES of [ * ] sold by CUBIST [ * ].
Royalties and Milestone Payments. 7 3.1. Royalties Payable by Modex............................. 7
Royalties and Milestone Payments. 4.1 Royalties. <OMITTED AND
Royalties and Milestone Payments. Seller shall pay to Buyer (a) milestone payments of up to $3 million in the aggregate with respect to the first pharmaceutical product developed by Buyer under the GPCR Directed Chemistry Program (the "Initial GPCR Product") and under the Solvay Agreement (the "Initial Solvay Product"), and (b) royalties on either the Initial GPCR Product or the Initial Solvay Product, whichever is commercialized first. The following milestones shall be paid upon the occurrence, if ever, of the following events: (A) $1 million upon Buyer's execution of an agreement with a third party collaborator for the development and commercialization of the Initial GPCR Product (the "First GPCR Event"), (B) $2 million upon commencement of Phase III clinical trials of the Initial GPCR Product, (C) $1 million upon commencement of Phase III clinical trials of the Initial Solvay
Royalties and Milestone Payments. 5.1 During the Term, or until this Agreement is earlier terminated, the Licensee agrees to pay the University a royalty of 1% of the world-wide Net Sales of Products.
